RasGAP-derived peptide GAP159 enhances cisplatin-induced cytotoxicity and apoptosis in HCT116 cells
To increase the efficacy of currently used anti-cancer genotoxins, one of the current efforts is to find agents that can sensitize cancer cells to genotoxins so that the efficacious doses of genotoxins can be lowered to reduce deleterious side-effects. In this study, we reported that a synthetic Ras...
Main Authors: | Hao Zhang, Shenghua Zhang, Hongwei He, Caixia Zhang, Yi Chen, Dongke Yu, Jianhua Chen, Rongguang Shao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-04-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383514000240 |
Similar Items
-
The Chinese medicine JC-001 enhances the chemosensitivity of Lewis lung tumors to cisplatin by modulating the immune response
by: Meng-Hsien Chuang, et al.
Published: (2017-04-01) -
Role of RasGAP and Caveolins in Cells Transfected with E-ras
by: Han-Yi Fu, et al.
Published: (2007) -
A RasGAP SH3 peptide aptamer inhibits RasGAP-Aurora interaction and induces caspase-independent tumor cell death.
by: Perayot Pamonsinlapatham, et al.
Published: (2008-01-01) -
The significance of MGMT protein detection in evaluation of osteosarcoma necrosis rate after cisplatin chemotherapy
by: Qiu Cui, et al.
Published: (2011-05-01) -
Study of a Molecular Promoter for Enhancing Cisplatin Cancer Chemotherapy
by: Nguyen, Jenny
Published: (2010)